Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.

McEvoy, Joseph P; Risinger, Robert; Mykhnyak, Serhiy; Du, Yangchun; Liu, Chih-Chin; Stanford, Arielle D; Weiden, Peter J

McEvoy, Joseph P; Risinger, Robert; Mykhnyak, Serhiy; Du, Yangchun; Liu, Chih-Chin; Stanford, Arielle D; Weiden, Peter J.

Affiliation

McEvoy JP; Department of Psychiatry and Health Behavior, Augusta University, 997 St Sebastian Way, Augusta, GA 30912. jmcevoy@augusta.edu.
Risinger R; Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
Mykhnyak S; Clinical Development, Alkermes, Inc., Waltham, Massachusetts, USA.
Du Y; Current affiliation: NeuroRx Pharmaceuticals, Wilmington, Delaware, USA.
Liu CC; Lviv District Clinical Psychiatric Hospital, Lviv, Ukraine.
Stanford AD; Clinical Development, Alkermes, Inc., Waltham, Massachusetts, USA.
Weiden PJ; Clinical Development, Alkermes, Inc., Waltham, Massachusetts, USA.

J Clin Psychiatry ; 78(8): 1103-1109, 2017.

Article in En | MEDLINE | ID: mdl-28937706

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Long-Term Care / Medication Adherence / Aripiprazole Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychiatry Year: 2017 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google